Prognostic Factors for Relapse in Patients With Clinical Stage I Testicular Seminoma: A Nationwide, Population-Based Cohort Study
Congratulations to all involved in the publication of the article just published in the Journal of Clinical Oncology about the prognostic factors for relapse in patients with clinical stage I seminoma, a testicular germ cell tumour. A special mention for Dan Berney whose work we are proud to support.
Here is a short excerpt of the report.
PURPOSE
Approximately 20% of patients with clinical stage I seminoma relapse. Tumor size and rete testis invasion have been identified as risk factors for relapse. However, the level of evidence supporting the use of these risk factors in clinical decision making is low. Previous studies have been hampered by selection bias and variable pathology reporting that limit interpretation and generalization of results. We assessed prognostic factors for relapse in an unselected nationwide population-based setting with centralized pathology review.
Thomas Wagner, Birgitte Grønkær Toft, Jakob Lauritsen, Mikkel Bandak, Ib Jarle Christensen, Birte Engvad, Michael Kreiberg, Mads Agerbæk, Lars Dysager, Josephine Julie Rosenvilde, Daniel Berney, and Gedske DaugaardJournal of Clinical Oncology 0 0:0